Embryonic stem cells improve cardiac function in doxorubicin-induced cardiomyopathy mediated through multiple mechanisms

Cell Transplantation

Volumn 21, Issue 9, 2012, Pages 1919-1930

  Singla, Dinender K ^a   Ahmed, Aisha ^a   Singla, Reetu ^a   Yan, Binbin ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Doxorubicin (DOX); Fibrosis; Heart; Stem cells

Indexed keywords

CASPASE 3; DOXORUBICIN; HEMOPOIETIC GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SOMATOMEDIN C; STEM CELL FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC STEM CELL; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL VACUOLE; CONTROLLED STUDY; DOXORUBICIN INDUCED CARDIOMYOPATHY; EMBRYONIC STEM CELL; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DOXORUBICIN; EMBRYONIC STEM CELLS; FIBROSIS; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

ANIMALIA; MUS;

EID: 84869821670     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X627552     Document Type: Article

References (39)

1. Agbulut, O.; Menot, M. L.; Li, Z.; Marotte, F.; 1.; Paulin, D.; Hagege, A. A.; Chomienne, C.; Samuel, J. L.; Menasche, P. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc. Res. 58:451-459; 2003.
2. Anversa, P.; Cheng, W.; Liu, Y.; Leri, A.; Redaelli, G.; Kajstura, J. Apoptosis and myocardial infarction. Basic Res. Cardiol. 93(Suppl 3):8-12; 1998.
3. Beltrami, A. P.; Barlucchi, L.; Torella, D.; Baker, M.; Limana, F.; Chimenti, S.; Kasahara, H.; Rota, M.; Musso, E.; Urbanek, K.; Leri, A.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776; 2003.
4. De Beer, E. L.; Bottone, A. E.; Voest, E. E. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: A review. Eur. J. Pharmacol. 415:1-11; 2001.
5. (+ve) progenitor cells and enhance neovascularization. Antioxid. Redox. Signal. 13:1857-1865; 2010.
6. Fujio, Y.; Nguyen, T.; Wencker, D.; Kitsis, R. N.; Walsh, K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101:660-667; 2000.
7. Garbade, J.; Dhein, S.; Lipinski, C.; Aupperle, H.; Arsalan, M.; Borger, M. A.; Barten, M. J.; Lehmann, S.; Walther, T.; Mohr, F. W. Bone marrow-derived stem cells attenuate impaired contractility and enhance capillary density in a rabbit model of doxorubicin-induced failing hearts. J. Card. Surg. 24:591-599; 2009.
8. Gautreau. A.; Poullet, P.; Louvard, D.; Arpin, M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96:7300-7305; 1999.
9. Haider, H. K.; Ashraf, M. Bone marrow cell transplantation in clinical perspective. J. Mol. Cell. Cardiol. 38:225-235; 2005.
10. Jugdutt, B. I.; Menon, V.; Kumar, D.; Idikio, H. Vascular remodeling during healing after myocardial infarction in the dog model: Effects of reperfusion, amlodipine and enalapril. J. Am. Coll. Cardiol. 39:1538-1545; 2002.
11. Kim, K. H.; Oudit, G. Y.; Backx, P. H. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. J. Pharmacol. Exp. Ther. 324:160-169; 2008.
12. Kumar, D.; Kirshenbaum, L.; Li, T.; Danelisen, I.; Singal, P. Apoptosis in isolated adult cardiomyocytes exposed to adriamycin. Ann. N. Y. Acad. Sci. 874:156-168; 1999.
13. Kumar, D.; Kirshenbaum, L. A.; Li, T.; Danelisen, I.; Singal, P. K. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid. Redox. Signal. 3:135-145; 2001.
14. Kumar, D.; Lou, H.; Singal, P. K. Oxidative stress and apoptosis in heart dysfunction. Herz 27:662-668; 2002.
15. Li, T. S.; Mikamo, A.; Takahashi, M.; Suzuki, R.; Ueda, K.; Ikeda, Y.; Matsuzaki, M.; Hamano, K. Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure. Cell Transplant. 16:365-374; 2007.
16. Li, T. S.; Takahashi, M.; Ohshima, M.; Qin, S. L.; Kubo, M.; Muramatsu, K.; Hamano, K. Myocardial repair achieved by the intramyocardial implantation of adult cardiomyocytes in combination with bone marrow cells. Cell Transplant. 17:695-703; 2008.
17. Liu, X. W.; Bernardo, M. M.; Fridman, R.; Kim, H. R. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J. Biol. Chem. 278:40364-40372; 2003.
18. Lorenz, K.; Schmitt, J. P.; Vidal, M.; Lohse, M. J. Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling. Int. J. Biochem. Cell Biol. 41:2351-2355; 2009.
19. Lou, H.; Danelisen, I.; Singal, P. K. Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 288:H1925-H1930; 2005.
20. Menasche, P. Myoblast-based cell transplantation. Heart Fail. Rev. 8:221-227; 2003.
21. Menasche P. Cellular transplantation: Hurdles remaining before widespread clinical use. Curr. Opin. Cardiol. 19:154-161; 2004.
22. Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56:185-229; 2004.
23. Mullonkal, C. J.; Toledo-Pereyra, L. H. Akt in ischemia and reperfusion. J. Invest. Surg. 20:195-203; 2007.
24. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S. M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705; 2001.
25. Orlic, D.; Kajstura, J.; Chimenti, S.; Limana, F.; Jakoniuk, I.; Quaini, F.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98:10344-10349; 2001.
26. Singal, P. K.; Iliskovic, N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339:900-905; 1998.
27. Singal, P. K.; Iliskovic, N.; Li, T.; Kumar, D. Adriamycin cardiomyopathy: Pathophysiology and prevention. FASEB J. 11:931-936; 1997.
28. Singla, D. K. Embryonic stem cells in cardiac repair and regeneration. Antioxid. Redox. Signal. 11:1857-1863; 2009.
29. Singla, D. K.; Lyons, G. E.; Kamp, T. J. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ. Physiol. 293:H1308-H1314, 2007.
30. Singla, D. K.; McDonald, D. E. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am. J. Physiol. Heart Circ. Physiol. 293:H1590-H1595; 2007.
31. Singla, D. K.; Singla, R. D.; Lamm, S.; Glass, C. TGF-{beta}2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium. Am. J. Physiol. Heart Circ. Physiol. 300:H1442-H1450; 2011.
32. Singla, D. K.; Singla, R. D.; McDonald, D. E. Factors Released from Embryonic Stem Cells inhibit Apoptosis in H9c2 cells through P1-3kinase/Akt but not ERK pathway. Am. J. Physiol. Heart Circ. Physiol. 295:H907-H913; 2008.
33. Spinale, F. G. Matrix metalloproteinases: Regulation and dysregulation in the failing heart. Circ. Res. 90:520-530; 2002.
34. Suliman, H. B.; Carraway, M. S.; Ali, A. S.; Reynolds, C. M.; Welty-Wolf, K. E.; Piantadosi, C. A. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J. Clin. Invest. 117:3730-3741; 2007.
35. Urbanek, K.; Rota, M.; Cascapera, S.; Bearzi, C.; Nascimbene, A.; De Angelis, A.; Hosoda, T.; Chimenti, S.; Baker, M.; Limana, F.; Nurzynska, D.; Torella, D.; Rotatori, F.; Rastaldo, R.; Musso, E.; Quaini, F.; Leri, A.; Kajstura, J.; Anversa, P. Cardiac stem cells possess growth factorreceptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 97:663-673; 2005.
36. Wang, X.; Jameel, M. N.; Li, Q.; Mansoor, A.; Qiang, X.; Swingen, C.; Panetta, C.; Zhang, J. Stem cells for myocardial repair with use of a transarterial catheter. Circulation 120:S238-S246; 2009.
37. Xiong, Q.; Hill, K. L.; Li, Q.; Suntharalingam, P.; Mansoor, A.; Wang, X.; Jameel, M. N.; Zhang, P.; Swingen, C.; Kaufman, D. S.; Zhang, J. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells 29:367-375, 2011.
38. Zhao, Y.; McLaughlin, D.; Robinson, E.; Harvey, A. P.; Hookham, M. B.; Shah, A. M.; McDermott, B. J.; Grieve, D. J. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res. 70:9287-9297; 2010.
39. Zhou, Y. L.; Zhang, H. F.; Li, X. L.; DI, R. M.; Yao, W. M.; Li, D. F.; Feng, J. L.; Huang, J.; Cao, K. J.; Fu, M. Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats. Chin. Med. J. (Engl.) 123:3282-3287; 2010.